Palatin Announces Presentation at the Eyecelerator@AAO 2022 Conference

/PRNewswire/ -- Palatin Technologies, Inc. ("Palatin") (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules...

Related Keywords

United States ,Chicago ,Illinois ,American ,Paul Kayne ,Palatin Progressing Development Programs In Retinal ,Sciences At Palatin ,Prnewswire Palatin Technologies Inc ,American Academy Of Ophthalmology ,Exchange Commission ,American Society Of Cataract ,Palatin Technologies Inc ,Overview Of Development Pipeline Melanocortins ,Securities Exchange ,Development Pipeline ,Ocular Conditions ,Resolving Inflammation ,Dry Eye Disease Currently Expected ,Progressing Development Programs ,Front Of The Eye Indications Supported ,Vice President ,Biological Sciences ,American Academy ,American Society ,Refractive Surgery ,Melanocortin Receptor Agonists ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Palatin Technologies ,